These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 16935390

  • 1. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G.
    J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
    [Abstract] [Full Text] [Related]

  • 2. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 3. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.
    Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK.
    J Immunol; 1997 Jan 15; 158(2):643-8. PubMed ID: 8992979
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N, Saio M, Suwa T, Ohe N, Yoshimura S, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Mol Med; 2004 Apr 15; 13(4):497-503. PubMed ID: 15010848
    [Abstract] [Full Text] [Related]

  • 6. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 7. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 15; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 10. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S, Komita H, Sagawa Y, Ohno T, Toda G.
    Immunology; 2005 Aug 15; 115(4):451-61. PubMed ID: 16011514
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
    Tang L, Hu HD, Hu P, Lan YH, Peng ML, Chen M, Ren H.
    Gene Ther; 2007 Aug 15; 14(16):1226-34. PubMed ID: 17597794
    [Abstract] [Full Text] [Related]

  • 12. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
    Søndergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K.
    J Immunother; 2010 Apr 15; 33(3):236-49. PubMed ID: 20445344
    [Abstract] [Full Text] [Related]

  • 13. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S.
    J Gastroenterol Hepatol; 2007 May 15; 22(5):690-6. PubMed ID: 17444857
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 15; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY, Lee J, Kim EY, Park HJ, Kwon CH, Joh JW, Kim SJ.
    BMC Cancer; 2007 May 23; 7():87. PubMed ID: 17519043
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.
    Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045
    [Abstract] [Full Text] [Related]

  • 17. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
    Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ.
    J Immunol; 1994 Aug 15; 153(4):1697-706. PubMed ID: 7913943
    [Abstract] [Full Text] [Related]

  • 18. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
    Apte SH, Groves P, Olver S, Baz A, Doolan DL, Kelso A, Kienzle N.
    J Immunol; 2010 Jul 15; 185(2):998-1004. PubMed ID: 20562261
    [Abstract] [Full Text] [Related]

  • 19. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M.
    Auris Nasus Larynx; 2004 Sep 15; 31(3):239-45. PubMed ID: 15364358
    [Abstract] [Full Text] [Related]

  • 20. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
    Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA.
    J Immunol; 1996 Jan 15; 156(2):693-9. PubMed ID: 8543822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.